LINZESS is widely available on commercial and Medicare Part D plans

86% of national commercial and Medicare Part D lives are not required to step through an OTC to receive LINZESS*

LINZESS is a preferred or covered** brand in:

*Managed Markets Insight and Technology, LLC^™, a trademark of MMIT. Database as of September 2023. Data are subject to change.

**Source: Market Access Account Managers (MAT) and Managed Markets Insight and Technology, LLC^TM, a trademark of MMIT, as of September 2023. Preferred is defined as product is on a preferred tier or otherwise has preferred status on the plan’s formulary. Covered is defined as product is on formulary and is not NDC blocked. Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits determined by respective plan administrators, insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient's coverage with applicable insurers. Formulary coverage does not imply efficacy or safety.